Corline Biomedical AB (STO:CLBIO)
Sweden flag Sweden · Delayed Price · Currency is SEK
16.20
-0.35 (-2.11%)
Feb 10, 2026, 5:29 PM CET

Corline Biomedical AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
5.8217.6717.0126.2141.648.99
Cash & Short-Term Investments
5.8217.6717.0126.2141.648.99
Cash Growth
-20.67%3.86%-35.09%-37.05%363.07%-60.66%
Accounts Receivable
0.6812.931.662.30.91
Other Receivables
0.21.632.296.820.470.45
Receivables
0.882.635.228.472.771.36
Prepaid Expenses
1.040.751.571.310.420.39
Total Current Assets
7.7421.0423.83644.8210.74
Property, Plant & Equipment
0.180.220.310.280.180.07
Long-Term Investments
000000
Long-Term Deferred Charges
74.3973.575.9965.556.6647.47
Total Assets
82.3194.76100.11101.78101.6658.28
Accounts Payable
1.123.091.974.341.961.44
Accrued Expenses
2.512.853.532.454.562.16
Other Current Liabilities
1.461.911.290.42.912.65
Total Current Liabilities
5.097.856.797.199.436.25
Total Liabilities
5.097.856.797.199.436.25
Common Stock
3.063.062.692.692.692.08
Additional Paid-In Capital
171.39171.39155.19155.19155.19115.27
Retained Earnings
-97.2237.3961.2754.9236.83-65.32
Comprehensive Income & Other
--124.92-125.83-118.21-102.47-
Shareholders' Equity
77.2386.9193.3294.5992.2352.03
Total Liabilities & Equity
82.3194.76100.11101.78101.6658.28
Net Cash (Debt)
5.8217.6717.0126.2141.648.99
Net Cash Growth
-20.67%3.86%-35.09%-37.05%363.07%-60.66%
Net Cash Per Share
0.240.810.791.192.040.54
Filing Date Shares Outstanding
21.4924.4921.4921.4921.4918.19
Total Common Shares Outstanding
21.4924.4921.4921.4921.4916.67
Working Capital
2.6513.217.0128.835.394.49
Book Value Per Share
3.593.554.344.404.293.12
Tangible Book Value
77.2386.9193.3294.5992.2352.03
Tangible Book Value Per Share
3.593.554.344.404.293.12
Machinery
-1.271.271.140.990.85
Source: S&P Global Market Intelligence. Standard template. Financial Sources.